Antibiotics, Vol. 12, Pages 16: Development of 3D-Printed Collagen Scaffolds with In-Situ Synthesis of Silver Nanoparticles

Figure 1. (A) Images of dry 3D-printed collagen-based scaffolds after in situ reduction of Ag by different UV irradiation intervals. Dimensions of 3D-printed collagen-based scaffolds are 6 mm × 6 mm × 2 mm. (B) Schematic illustration of the mechanism of in situ AgNPs formation by using the UV irradiation method.

Figure 1. (A) Images of dry 3D-printed collagen-based scaffolds after in situ reduction of Ag by different UV irradiation intervals. Dimensions of 3D-printed collagen-based scaffolds are 6 mm × 6 mm × 2 mm. (B) Schematic illustration of the mechanism of in situ AgNPs formation by using the UV irradiation method.

Antibiotics 12 00016 g001

Figure 2. SEM images of (A): Col-Ag0.05-2; (B): Col-Ag0.05-4; (C): Col-Ag0.05-6; (D): Col-Ag0.1-2; (E): Col-Ag0.1-4; (F): Col-Ag0.1-6. (G): Representative EDS analysis of Col-Ag.

Figure 2. SEM images of (A): Col-Ag0.05-2; (B): Col-Ag0.05-4; (C): Col-Ag0.05-6; (D): Col-Ag0.1-2; (E): Col-Ag0.1-4; (F): Col-Ag0.1-6. (G): Representative EDS analysis of Col-Ag.

Antibiotics 12 00016 g002

Figure 3. TEM images of the AgNPs formed inside the 3D-printed collagen-based scaffolds. (A): Col-Ag0.05-2; (B): Col-Ag0.05-4; (C): Col-Ag0.05-6; (D): Col-Ag0.1-2; (E): Col-Ag0.1-4; (F): Col-Ag0.1-6. (G): schematic illustration of the variation of the size of the silver particles according to the place of the material where they are formed.

Figure 3. TEM images of the AgNPs formed inside the 3D-printed collagen-based scaffolds. (A): Col-Ag0.05-2; (B): Col-Ag0.05-4; (C): Col-Ag0.05-6; (D): Col-Ag0.1-2; (E): Col-Ag0.1-4; (F): Col-Ag0.1-6. (G): schematic illustration of the variation of the size of the silver particles according to the place of the material where they are formed.

Antibiotics 12 00016 g003

Figure 4. FTIR spectra of Col, Col-Ag0.05 (A), and Col-Ag0.1 (B) after different time of UV light exposure (0 h, 2 h, 4 h, and 6 h).

Figure 4. FTIR spectra of Col, Col-Ag0.05 (A), and Col-Ag0.1 (B) after different time of UV light exposure (0 h, 2 h, 4 h, and 6 h).

Antibiotics 12 00016 g004

Figure 5. Silver content in 3D-printed Col-Ag0.05 and Col-Ag0.1 scaffolds, after 2 h, 4 h, and 6 h of UV irradiation, measured by Atomic Absorption spectroscopy.

Figure 5. Silver content in 3D-printed Col-Ag0.05 and Col-Ag0.1 scaffolds, after 2 h, 4 h, and 6 h of UV irradiation, measured by Atomic Absorption spectroscopy.

Antibiotics 12 00016 g005

Figure 6. DSC thermal analyses for 3D-printed Col (A), Col-Ag0.05 (B), and Col-Ag0.1 (C) scaffolds after different UV irradiation times.

Figure 6. DSC thermal analyses for 3D-printed Col (A), Col-Ag0.05 (B), and Col-Ag0.1 (C) scaffolds after different UV irradiation times.

Antibiotics 12 00016 g006

Figure 7. Collagenase degradation test of 3D-printed collagen-based scaffolds. Weight percentage is shown as a function of time comparing Col with Col-Ag0.05 (A), and Col with Col-0.1 (B). Col-2(--●--blue), Col-4(--●--green), Col-6 (--●--red), Col-Ag0.05-2 (-■-blue), Col-Ag0.05-4 (-■-green), Col-Ag0.05-6 (-■-red), Col-Ag0.05-2 (-▲-blue), Col-Ag0.05-4 (-▲-green), and Col-Ag0.05-6 (-▲-red). Results are expressed as mean ± SD from triplicate experiments.

Figure 7. Collagenase degradation test of 3D-printed collagen-based scaffolds. Weight percentage is shown as a function of time comparing Col with Col-Ag0.05 (A), and Col with Col-0.1 (B). Col-2(--●--blue), Col-4(--●--green), Col-6 (--●--red), Col-Ag0.05-2 (-■-blue), Col-Ag0.05-4 (-■-green), Col-Ag0.05-6 (-■-red), Col-Ag0.05-2 (-▲-blue), Col-Ag0.05-4 (-▲-green), and Col-Ag0.05-6 (-▲-red). Results are expressed as mean ± SD from triplicate experiments.

Antibiotics 12 00016 g007

Figure 8. Swelling capacity of Col-Ag0.05 (A) and Col-Ag0.1 (B). Col-2(--●--blue), Col-4(--●--green), Col-6 (--●--red), Col-Ag0.05-2 (-■-blue), Col-Ag0.05-4 (-■-green), Col-Ag0.05-6 (-■-red), Col-Ag0.05-2 (-▲-blue), Col-Ag0.05-4 (-▲-green), and Col-Ag0.05-6 (-▲-red). Results are expressed as mean ± SD from triplicate experiments.

Figure 8. Swelling capacity of Col-Ag0.05 (A) and Col-Ag0.1 (B). Col-2(--●--blue), Col-4(--●--green), Col-6 (--●--red), Col-Ag0.05-2 (-■-blue), Col-Ag0.05-4 (-■-green), Col-Ag0.05-6 (-■-red), Col-Ag0.05-2 (-▲-blue), Col-Ag0.05-4 (-▲-green), and Col-Ag0.05-6 (-▲-red). Results are expressed as mean ± SD from triplicate experiments.

Antibiotics 12 00016 g008

Figure 9. Antimicrobial activity of 3D-printed Col and Col-Ag gels against E. coli. (A) Disk diffusion method. (B) Percentage of growth inhibition, evaluated by the dilution method.

Figure 9. Antimicrobial activity of 3D-printed Col and Col-Ag gels against E. coli. (A) Disk diffusion method. (B) Percentage of growth inhibition, evaluated by the dilution method.

Antibiotics 12 00016 g009

Figure 10. Antimicrobial activity of silver in 3D-printed Col and Col-Ag gels against S. aureus. (A) Disk diffusion method. (B) Percentage of growth inhibition, evaluated by the dilution method.

Figure 10. Antimicrobial activity of silver in 3D-printed Col and Col-Ag gels against S. aureus. (A) Disk diffusion method. (B) Percentage of growth inhibition, evaluated by the dilution method.

Antibiotics 12 00016 g010

Table 1. Size of AgNPs formed in situ, inside the 3D-printed collagen-based scaffolds.

Table 1. Size of AgNPs formed in situ, inside the 3D-printed collagen-based scaffolds.

SampleAgNPs Size (nm)Col-Ag0.05-226.17 ± 5.53Col-Ag0.05-427.70 ± 7.45Col-Ag0.05-624.39 ± 7.50Col-Ag0.1-212.02 ± 3.34Col-Ag0.1-49.74 ± 2.23Col-Ag0.1-610.18 ± 2.45

留言 (0)

沒有登入
gif